Gemina Laboratories Ltd. (GLABF)
USD 0.92
(17.08%)
USD 0.92
(17.08%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 5.08 Million CAD | -14.95% |
| 2023 | 5.98 Million CAD | 26.31% |
| 2022 | 4.73 Million CAD | 647.33% |
| 2021 | 633.5 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.7 Million CAD | -12.71% |
| 2024 FY | 5.1 Million CAD | -14.65% |
| 2024 Q4 | 1.01 Million CAD | 14.21% |
| 2024 Q3 | 886.05 Thousand CAD | -43.85% |
| 2024 Q2 | 1.57 Million CAD | -7.65% |
| 2023 Q4 | 1.95 Million CAD | 56.46% |
| 2023 Q1 | 780.77 Thousand CAD | -40.03% |
| 2023 Q2 | 1.99 Million CAD | 154.92% |
| 2023 FY | 5.98 Million CAD | 26.31% |
| 2023 Q3 | 1.25 Million CAD | -37.13% |
| 2022 Q3 | 1.51 Million CAD | 98.26% |
| 2022 Q2 | 766.34 Thousand CAD | -32.96% |
| 2022 Q1 | 1.14 Million CAD | 28.12% |
| 2022 FY | 4.73 Million CAD | 647.33% |
| 2022 Q4 | 1.3 Million CAD | -14.31% |
| 2021 FY | 633.5 Thousand CAD | 0.0% |
| 2021 Q2 | 52.67 Thousand CAD | 0.0% |
| 2021 Q3 | 163.99 Thousand CAD | 211.34% |
| 2021 Q4 | 892.24 Thousand CAD | 444.08% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 10.86 Million USD | 53.199% |
| Skye Bioscience, Inc. | 13.54 Million USD | 62.459% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 86.349% |
| Nascent Biotech, Inc. | 2.22 Million USD | -128.079% |
| Qrons Inc. | 643.67 Thousand USD | -690.13% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -1124.101% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -0.869% |
| BioStem Technologies, Inc. | 22.97 Million USD | 77.863% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -450.712% |
| CSL Limited | 3.44 Billion USD | 99.853% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 91.146% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 82.791% |
| Rebus Holdings, Inc. | 664 Thousand USD | -665.946% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -280.842% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -1205.525% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 68.234% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 94.14% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -3.415% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -1843.209% |
| SQZ Biotechnologies Company | 85.61 Million USD | 94.06% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -74.399% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -238.63% |
| Mesoblast Limited | 5.9 Million USD | 13.828% |
| Marizyme, Inc. | 19.23 Million USD | 73.566% |
| Genus plc | 147.7 Million USD | 96.557% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 42.069% |
| Pharming Group N.V. | 225.49 Million USD | 97.745% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -148.249% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -279.106% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 39.011% |
| ContraFect Corporation | 56.88 Million USD | 91.06% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -15.361% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -243.931% |
| IMV Inc. | 37.7 Million USD | 86.513% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -82.266% |
| MultiCell Technologies, Inc. | 567.42 USD | -896217.19% |
| ONE Bio Corp. | 6.44 Million USD | 21.074% |
| Accustem Sciences Inc. | 3.74 Million USD | -35.753% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 94.082% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -856.061% |
| Q BioMed Inc. | 3.43 Million USD | -47.991% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 79.422% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -93.562% |
| Biomind Labs Inc. | 994.18 Thousand USD | -411.565% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 94.88% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -189.024% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 24.295% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -172.794% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 20443.532% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -177.145% |
| GB Sciences, Inc. | 1.42 Million USD | -258.032% |
| Alpha Cognition Inc. | 9.7 Million USD | 47.598% |
| HST Global, Inc. | 140.9 Thousand USD | -3509.39% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -352.115% |
| Halberd Corporation | 74.84 Thousand USD | -6695.493% |
| Enzolytics Inc. | 2.17 Million USD | -133.35% |
| Agentix Corp. | 1.37 Million USD | -270.757% |
| Resverlogix Corp. | 12.71 Million USD | 59.991% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -39.312% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 99.668% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -387.154% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -111.477% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -222.023% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -49.366% |
| AVAX Technologies, Inc. | 7.31 Million USD | 30.428% |
| Zenith Capital Corp. | 8.94 Million USD | 43.13% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.384% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -29093.979% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -107.138% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -2865.374% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -164.765% |
| Kadimastem Ltd | 2.41 Million USD | -111.023% |
| Helix BioMedix, Inc. | 1.97 Million USD | -157.9% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -2702.371% |
| LadRx Corporation | 3.81 Million USD | -33.425% |
| Cell Source, Inc. | 4.32 Million USD | -17.583% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -450.712% |
| NovAccess Global Inc. | 2.46 Million USD | -106.177% |
| Affymax, Inc. | 39.38 Million USD | 87.087% |
| Itoco Inc. | 919.14 Thousand USD | -453.329% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -19.995% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -354.503% |
| Mobile Lads Corp. | 554.54 Thousand USD | -817.126% |
| CytoDyn Inc. | 18.05 Million USD | 71.836% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -20106.933% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -2210.946% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -258.213% |
| SYBLEU INC | 160.87 Thousand USD | -3061.368% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -180.01% |
| International Stem Cell Corporation | 5.27 Million USD | 3.512% |
| Bioxytran, Inc. | 3.82 Million USD | -33.133% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -9561.265% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -24900.654% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 85.976% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -214.331% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -591.172% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -63.481% |
| Neutra Corp. | 243.82 Thousand USD | -1985.909% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 70.866% |
| PureTech Health plc | 144.59 Million USD | 96.483% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 75.179% |
| IXICO plc | 4.7 Million USD | -8.049% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 42.186% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 95.681% |
| CSL Limited | 3.89 Billion USD | 99.869% |
| Cellectis S.A. | 97.32 Million USD | 94.774% |